Indactiv 320 Capsule contains a combination of Indacaterol (150 mcg) and Mometasone (320 mcg), formulated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. Indacaterol is a long-acting beta2-adrenergic receptor agonist (LABA) that provides sustained bronchodilation by relaxing airway smooth muscle, thereby improving airflow and reducing symptoms such as wheezing, shortness of breath, and coughing. Mometasone is a potent inhaled corticosteroid with anti-inflammatory properties that suppresses airway inflammation, decreases mucus production, and reduces airway hyperresponsiveness. The combined action of Indacaterol and Mometasone in Indactiv 320 Capsule offers both bronchodilation and anti-inflammatory effects, leading to improved lung function and better symptom control in patients with obstructive airway diseases. This combination is intended for regular use to prevent exacerbations and improve quality of life but is not suitable for relief of acute bronchospasm. Patients should use Indactiv 320 Capsule as prescribed by a healthcare professional and adhere to the recommended dosage regimen. Common side effects may include headache, nasopharyngitis, and throat irritation. Patients with hypersensitivity to any component should avoid use. Regular monitoring is advised to assess efficacy and detect potential adverse effects.